Peterson J, Drazan D, Moughan B, Maguire JD, et al. Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose. Vaccine 2024;43.
PMID: 39520893